These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 20297863)

  • 1. Isotretinoin use and compliance with the Dutch Pregnancy Prevention Programme: a retrospective cohort study in females of reproductive age using pharmacy dispensing data.
    Teichert M; Visser LE; Dufour M; Rodenburg E; Straus SM; De Smet PA; Stricker BH
    Drug Saf; 2010 Apr; 33(4):315-26. PubMed ID: 20297863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescriptive contraceptive use among isotretinoin users in the Netherlands in comparison with non-users: a drug utilisation study.
    Crijns HJ; van Rein N; Gispen-de Wied CC; Straus SM; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2012 Oct; 21(10):1060-6. PubMed ID: 22228673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Isotretinoin: compliance with recommendations in childbearing women].
    Bensouda-Grimaldi L; Jonville-Béra AP; Mouret E; Elefant E; Dhellot H; Delmas C; Gouin T; Coste P; Autret-Leca E;
    Ann Dermatol Venereol; 2005 May; 132(5):415-23. PubMed ID: 15988352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs associated with teratogenic mechanisms. Part I: dispensing rates among pregnant women in the Netherlands, 1998-2009.
    van Gelder MM; Bos JH; Roeleveld N; de Jong-van den Berg LT
    Hum Reprod; 2014 Jan; 29(1):161-7. PubMed ID: 24105826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of compliance with isotretinoin PPP recommendations and exploration of reasons for non-compliance: Survey among French-speaking health care professionals and patients in Belgium.
    Lelubre M; Hamdani J; Senterre C; Amighi K; Peres M; Schneider MP; Bugnon O; De Vriese C
    Pharmacoepidemiol Drug Saf; 2018 Jun; 27(6):668-673. PubMed ID: 29726056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance with pregnancy prevention programmes of isotretinoin in Europe: a systematic review.
    Crijns HJ; Straus SM; Gispen-de Wied C; de Jong-van den Berg LT
    Br J Dermatol; 2011 Feb; 164(2):238-44. PubMed ID: 20716214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of drug consultation center guidance on contraceptive use among women using isotretinoin: a randomized, controlled study.
    Tsur L; Kozer E; Berkovitch M
    J Womens Health (Larchmt); 2008 May; 17(4):579-84. PubMed ID: 18447762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare professional surveys to investigate the implementation of the isotretinoin Pregnancy Prevention Programme: a descriptive study.
    Crijns I; Mantel-Teeuwisse A; Bloemberg R; Pinas E; Straus S; de Jong-van den Berg L
    Expert Opin Drug Saf; 2013 Jan; 12(1):29-38. PubMed ID: 23163396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant use of isotretinoin and contraceptives before and after iPledge in the United States.
    Pinheiro SP; Kang EM; Kim CY; Governale LA; Zhou EH; Hammad TA
    Pharmacoepidemiol Drug Saf; 2013 Dec; 22(12):1251-7. PubMed ID: 23913625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant use of contraceptives and potentially teratogenic medicinal products--results from a study using pharmacy dispensing data in the Netherlands.
    Ruiter R; Teichert M; Straus SM; Stricker BH; Visser LE
    Reprod Sci; 2012 Sep; 19(9):987-94. PubMed ID: 22527986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isotretinoin and oral contraceptive use in female acne patients varies by physician specialty: analysis of data from the National Ambulatory Medical Care Survey.
    Landis ET; Levender MM; Davis SA; Feneran AN; Gerancher KR; Feldman SR
    J Dermatolog Treat; 2012 Aug; 23(4):272-7. PubMed ID: 22380867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compliance with pregnancy prevention measures during isotretinoin therapy.
    Collins MK; Moreau JF; Opel D; Swan J; Prevost N; Hastings M; Bimla Schwarz E; Korb Ferris L
    J Am Acad Dermatol; 2014 Jan; 70(1):55-9. PubMed ID: 24157382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription retinoid and contraception use in women in Australia: A population-based study.
    Gerhardy L; Nassar N; Litchfield M; Kennedy D; Smith A; Gillies MB; Pearson SA; Zoega H; Shand A
    Australas J Dermatol; 2024 Aug; 65(5):428-436. PubMed ID: 38693687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in adherence to a revised risk management program designed to decrease or eliminate isotretinoin-exposed pregnancies: evaluation of the accutane SMART program.
    Brinker A; Kornegay C; Nourjah P
    Arch Dermatol; 2005 May; 141(5):563-9. PubMed ID: 15897377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Exposure to isotretinoin during pregnancy in France: 25 years of follow-up].
    Rouzès A; Jonville-Béra AP
    Therapie; 2014; 69(1):53-63. PubMed ID: 24698189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continued occurrence of Accutane-exposed pregnancies.
    Honein MA; Paulozzi LJ; Erickson JD
    Teratology; 2001 Sep; 64(3):142-7. PubMed ID: 11514944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accutane-exposed pregnancies--California, 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Jan; 49(2):28-31. PubMed ID: 10680601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent use of hormonal long-acting reversible contraception by women of reproductive age dispensed teratogenic medications, Australia, 2013-2021: a retrospective cohort study.
    Grzeskowiak LE; Moore V; Hall K; Ilomäki J; Schoenaker D; Lovegrove E; Mazza D; Black KI; Kennedy DS; Davies MJ; Rumbold A
    Med J Aust; 2024 Oct; 221(7):367-373. PubMed ID: 39285147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermatologists' level of compliance with the prescription guidelines of isotretinoin for females of childbearing potential.
    AlGhamdi KM; Khurram H; Asiri YA; Mandil A
    Int J Dermatol; 2011 Sep; 50(9):1094-8. PubMed ID: 22126870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Isotretinoin (Roaccutane) in women of childbearing age: failure of following prescription guidelines].
    Autret E; Radal M; Jonville-Béra AP; Goehrs JM
    Ann Dermatol Venereol; 1997; 124(8):518-22. PubMed ID: 9740842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.